Page last updated: 2024-08-23

bm 13505 and ridogrel

bm 13505 has been researched along with ridogrel in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cozzi, P; Ferrario, R; Giordani, A; Menichincheri, M; Pillan, A; Pinciroli, V; Rossi, A; Tamburin, M; Tonani, R; Volpi, D1

Other Studies

1 other study(ies) available for bm 13505 and ridogrel

ArticleYear
Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.
    Journal of medicinal chemistry, 1994, Oct-14, Volume: 37, Issue:21

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Binding, Competitive; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Computer Simulation; Dogs; Fatty Acids, Unsaturated; Fibrinolytic Agents; Humans; Hydrazines; Imidazoles; Male; Models, Molecular; Molecular Structure; Pentanoic Acids; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Stereoisomerism; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase

1994